Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Enrico Girardi and Andrea Antinori.
Connection Strength

1.241
  1. No Efficacy of the Combination of Lopinavir/Ritonavir Plus Hydroxychloroquine Versus Standard of Care in Patients Hospitalized With COVID-19: A Non-Randomized Comparison. Front Pharmacol. 2021; 12:621676.
    View in: PubMed
    Score: 0.235
  2. COVID-19 in people living with HIV: Clinical implications of dynamics of the immune response to SARS-CoV-2. J Med Virol. 2021 03; 93(3):1796-1804.
    View in: PubMed
    Score: 0.227
  3. Evidence-based renewal of the Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. New Microbiol. 2018 10; 41(4):247-255.
    View in: PubMed
    Score: 0.197
  4. Prophylactic heparin and risk of orotracheal intubation or death in patients with mild or moderate COVID-19 pneumonia. Sci Rep. 2021 05 31; 11(1):11334.
    View in: PubMed
    Score: 0.059
  5. Role of testosterone in SARS-CoV-2 infection: A key pathogenic factor and a biomarker for severe pneumonia. Int J Infect Dis. 2021 Jul; 108:244-251.
    View in: PubMed
    Score: 0.059
  6. Risk and predictive factors of prolonged viral RNA shedding in upper respiratory specimens in a large cohort of COVID-19 patients admitted to an Italian reference hospital. Int J Infect Dis. 2021 Apr; 105:532-539.
    View in: PubMed
    Score: 0.058
  7. Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection. PLoS One. 2021; 16(2):e0247275.
    View in: PubMed
    Score: 0.058
  8. COVID-19 disease-Temporal analyses of complete blood count parameters over course of illness, and relationship to patient demographics and management outcomes in survivors and non-survivors: A longitudinal descriptive cohort study. PLoS One. 2020; 15(12):e0244129.
    View in: PubMed
    Score: 0.058
  9. A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients. Clin Microbiol Infect. 2021 Feb; 27(2):286.e7-286.e13.
    View in: PubMed
    Score: 0.057
  10. Genetic divergence of HIV-1 B subtype in Italy over the years 2003-2016 and impact on CTL escape prevalence. Sci Rep. 2018 10 24; 8(1):15739.
    View in: PubMed
    Score: 0.049
  11. Brief Report: Drop in CD4+ Counts Below 200 Cells/µL After Reaching (or Starting From) Values Higher than 350 Cells/µL in HIV-Infected Patients With Virological Suppression. J Acquir Immune Defic Syndr. 2017 12 01; 76(4):417-422.
    View in: PubMed
    Score: 0.047
  12. Projections of non-communicable disease and health care costs among HIV-positive persons in Italy and the U.S.A.: A modelling study. PLoS One. 2017; 12(10):e0186638.
    View in: PubMed
    Score: 0.046
  13. Slow or fast viral load decay as a predictor of residual viremia level in HIV-infected patients undergoing successful first-line cART. New Microbiol. 2017 Oct; 40(4):234-241.
    View in: PubMed
    Score: 0.046
  14. Access and response to direct antiviral agents (DAA) in HIV-HCV co-infected patients in Italy: Data from the Icona cohort. PLoS One. 2017; 12(5):e0177402.
    View in: PubMed
    Score: 0.045
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.